VYGR (Voyager Therapeutics) Volume dana dhuwit perusahaan

Logo grafis Voyager Therapeutics (VYGR)

Geopolitical risks and overseas patent disputes may hinder the registration of Voyager Therapeutics (VYGR) drugs, which is why the GURU.Markets terminal displays the company's cash asset chart, where the 0.11 metric serves as the target level. Stable demand for neuromedicine renders the business non-cyclical, while optimized biotech hubs guarantee seamless raw material logistics for research laboratories.

Total volume dana dhuwit perusahaan: Voyager Therapeutics Inc (VYGR) kanggo 04.07.2022 - 21.11.2026

Rincian analitis perusahaan Voyager Therapeutics

- nilai saham lan prakiraan konsensus rega:
Ringkesan analisis perusahaan:voyagertherapeutics.com
Sampel barang Voyager Therapeutics Inc

Voyager Therapeutics (VYGR) is developing sophisticated gene delivery technologies for the treatment of neurodegenerative diseases, which require colossal R&D investments. This indicator digitizes the liquid reserves necessary to fund clinical trials and the development of viral vectors. The metric measures the business's ability to sustain operations without external borrowing, balancing financial stability with capital efficiency. By analyzing the company's cash dynamics, an investor assesses the time horizon of the company's autonomy until the commercialization of its products.

Pesaing utama

Volume dana dhuwit perusahaan BIIB|Dana dhuwit perusahaan NBIX (Neurocrine Biosciences)|Dana dhuwit perusahaan Regencell Bioscience Ltd RGC|AXSM (Axsome Therapeutics, Inc.) - Total volume dana dhuwit perusahaan|ACADIA Corp - Volume dana dhuwit perusahaan|Cadangan dhuwit perusahaan Xenon Pharmaceuticals|VKTX (Viking Therapeutics Corp) - Dhuwit awis perusahaan|Supernus Pharmaceuticals (SUPN) - Volume dana dhuwit perusahaan|CPRX (Catalyst Pharma) - Volume dana dhuwit perusahaan|DNLI (Denali Therapeutics Inc.) - Gunggung dana dhuwit perusahaan|Volume dana dhuwit perusahaan HRMY|Biohaven Corp - Dhuwit awis lan setara dhuwit awis perusahaan|Volume dana dhuwit perusahaan AMLX (amylyx.com)|Aset likuid perusahaan Trevi Therapeutics, Inc. (TRVI)|Praxis Corp - Volume dana dhuwit perusahaan|Cadangan dhuwit perusahaan Anavex|CBLL (CeriBell Inc) - Dhuwit awis perusahaan|Dhuwit awis lan setara dhuwit awis perusahaan PRTA|Dana dhuwit perusahaan Alector Inc.|Cadangan dhuwit perusahaan Annexon, Inc. ANNX|Dana dhuwit perusahaan Omeros Corp (OMER)|NGNE (Neurogene Inc) - Sisa dhuwit perusahaan|Dana dhuwit perusahaan AC Immune Inc ACIU|Sisa dhuwit perusahaan NMRA|scilexholding.com - Volume dana dhuwit perusahaan|TVGN (tevogen.com) - Dhuwit awis lan setara dhuwit awis perusahaan|ACOG: Volume dana dhuwit perusahaan|CGTX: Gunggung dana dhuwit perusahaan|Dana dhuwit perusahaan Inhibikase Therapeutics|Dhuwit awis lan setara dhuwit awis perusahaan SAVA (Cassava)|Dana dhuwit perusahaan Assertio Therapeutics (ASRT)|Coya Therapeutics - Dhuwit awis lan setara dhuwit awis perusahaan|VistaGen Therapeutics, Inc. - Dhuwit awis perusahaan|ovidrx.com (OVID) - Cadangan dhuwit perusahaan|ABOS: Dhuwit awis perusahaan|Cadangan dhuwit perusahaan CervoMed Inc|alteritytherapeutics.com (ATHE) - Dana dhuwit perusahaan|Dhuwit awis perusahaan Clene Nanomedicine|Dhuwit awis perusahaan PEPG|Cadangan dhuwit perusahaan Jupiter Neurosciences JUNS|Dana dhuwit perusahaan Relmada (RLMD)|Aset likuid perusahaan Annovis Bio, Inc.|Volume dana dhuwit perusahaan GRCE (Grace Tx)|Firefly Neuroscience, Inc (AIFF) - Cadangan dhuwit perusahaan|KLTO - Dana dhuwit perusahaan|Cadangan dhuwit perusahaan NeuroSense Therapeutics Ltd|RVPH: Volume dana dhuwit perusahaan|MetaVia, Inc. (MTVA) - Volume dana dhuwit perusahaan|Dana dhuwit perusahaan NeurAxis|Volume dana dhuwit perusahaan heliusmedical.com|Dhuwit awis perusahaan PASG (Passage Bio Inc.)|Neuphoria Therapeutics - Dhuwit awis lan setara dhuwit awis perusahaan|Minerva Neurosciences Corp - Dhuwit awis perusahaan|Sisa dhuwit perusahaan ATHA|ADXN - Dana dhuwit perusahaan|Cadangan dhuwit perusahaan Alzamend Neuro Inc.|Cyclerion Therapeutics (CYCN) - Dana dhuwit perusahaan|Dhuwit awis lan setara dhuwit awis perusahaan PTIX|KTTA (pasitheaclinics.com) - Volume dana dhuwit perusahaan|CRGT (cortigent.com) - Gunggung dana dhuwit perusahaan|Volume dana dhuwit perusahaan ATXI|Dana dhuwit perusahaan BCLI (Brainstorm Cell)|Volume dana dhuwit perusahaan CARA (Cara Therapeutics Inc)|Sisa dhuwit perusahaan CHRO|Eliem Therapeutics Inc. - Volume dana dhuwit perusahaan|ITCI - Volume dana dhuwit perusahaan|Longboard Pharma (LBPH) - Dana dhuwit perusahaan|Dhuwit awis perusahaan Marinus Pharmaceuticals|Dana dhuwit perusahaan NKGen|Volume dana dhuwit perusahaan NeuroBo Pharmaceuticals, Inc.|Volume dana dhuwit perusahaan SAGE|Synaptogenix, Inc - Dhuwit awis lan setara dhuwit awis perusahaan|Dana dhuwit perusahaan Trevena TRVN|Posisi dhuwit perusahaan Vigil Neuroscience|Anew Medical Inc. - Volume dana dhuwit perusahaan|Aset likuid perusahaan Cerevel Therapeutics, Inc. CERE